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Abstract
Background: Lysophospholipids such as lysophosphatidic acid (LPA) and sphingosine-1-phosphate (S1P) are important
signaling molecules that can regulate a wide range of cellular responses. We discovered that Sphingosine kinase 1 (Sphk1), a
key enzyme that converts sphingosine to S1P, is expressed in neurons and progenitor cells in nascent trigeminal and dorsal
root ganglia during mouse embryogenesis.
Methods and Findings: Sphk1 null mouse embryos do not display overt deficits owing to compensation by Sphk2. Thus, we
analyzed embryos that are deficient in both Sphk1 and Sphk2 (which essentially eliminates S1P function) in order to
investigate the role(s) of Sphk1 during sensory ganglia formation. While animals lacking 1–3 alleles of Sphk1 and Sphk2 had
no obvious phenotype, embryos without both genes displayed clear developmental defects. The complete absence of
Sphk1 and Sphk2 resulted in trigeminal and dorsal root ganglia with fewer neurons and progenitor cells. The profound loss
in cell number could be attributed to a decrease in cell proliferation as well as an increase in apoptosis. Furthermore, Sphk1/
2 double mutants displayed an overall reduction in other sphingolipids as well as an imbalance of S1P/sphingosine and S1P/
ceramide ratio, thereby favoring cell death and reducing cell growth.
Conclusions: Together, these results provide strong in vivo evidence that sphingosine kinase/S1P signaling plays an
important role in regulating early events during development of sensory ganglia.
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Introduction
Sensory neurons convey senses, among others, of touch,
temperature, and proprioception from the periphery to the central
nervous system. The sensory system is made up of the cranial
ganglia (which include the trigeminal ganglia and dorsal root
ganglia). Both neurons and glia in the dorsal root ganglion are
derived from the multipotent neural crest cells and the trigeminal
ganglion receives additional neuronal contribution from the
trigeminal placode in the head [1]. As sensory neurons
differentiate and innervate target sites, their survival is supported
by neurotrophic factors such as the family of neurotrophins
[2,3,4,5]. On the other hand, what regulate progenitor cell
proliferation and neuronal survival during early ganglia develop-
ment is less well understood. Ciliary neurotrophic factor and
neurotrophin-3 have been demonstrated to induce proliferation of
progenitor cells and neuronal differentiation in immature dorsal
root ganglia [6]. We recently discovered that Sphingosine kinase 1
was expressed in progenitor cells and a subset of neurons in the
nascent sensory ganglia and hypothesized that the Sphingosine
kinase/sphingosine-1-phosphate could mediate cell proliferation
and survival prior to target innervation.
Lysophospholipids such as lysophosphatidic acid (LPA) and
sphingosine-1-phosphate (S1P) are membrane-derived bioactive
lipid mediators [7,8,9]. S1P, its precursor, sphingosine, and
ceramide are sphingolipids that have been studied by many
groups as they are involved in signaling pathways that control
multiple cellular processes including cell proliferation, differenti-
ation, survival and migration ([8,9,10,11]. Sphingosine is phos-
phorylated by Sphingosine kinases to form S1P [12] and
sphingosine can be generated either by degradation of sphingo-
lipids or by deacylation of ceramide. S1P can be dephosphorylated
by Sphingosine-1-phosphate phosphatases 1 and 2 (Sgpp1 and Sgpp2)o r
by lipid phosphohydrolases with broader substrate specificity.
Alternatively, S1P can be irreversibly degraded to ethanolamine
phosphate and hexadecenal (long chain aldehyde) by the action of
sphingosine-1-phosphate lyase.
Sphingolipids regulate cell growth and survival in many cell
types. S1P is usually associated with cell proliferation and survival;
in contrast, ceramide and sphingosine are usually associated with
cell death [11,12,13,14]. Stressful stimuli or growth factor
withdrawal can activate sphingomyelinase, which converts sphin-
gomyelin to produce ceramide. Ceramide can take part in multiple
events that lead to stress response, growth arrest, or apoptosis. The
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sphingosine, which can inhibit protein kinase C and induce
apoptosis. Thus, the relative levels of S1P, ceramide, and
sphingosine inside a cell can influence survival or apoptosis
[13,14,15]. These sphingolipid molecules are interconvertible,
higher level of S1P favors cell growth, whereas cell death ensues
when the reaction tends towards sphingosine/ceramide; thus, this
balance is sometimes referred to the ‘‘sphingolipid rheostat’’
[16,17,18]. Of all the molecules that participate in the sphingolipid
rheostat, Sphingosine kinase is particularly important because it can
decrease ceramide and sphingosine by catalyzing the formation of
S1P. In mammals, two sphingosine kinases, Sphingosine kinase 1
(Sphk1) and Sphingosine kinsae 2 (Sphk2) have been identified. The
biological function of Sphk2 is controversial and less well
characterized than Sphk1. Sphk1 is upregulated in several types of
cancers, including cancer of the colon, breast, stomach, and kidney
[18]. Additional evidence also suggested that tumor cells can
overexpress Sphk1, implicating the S1P pathway in the uncon-
trolled growth and dampening of cell death associated with
cancers [18].
Many actions of S1P are mediated by G protein coupled
receptors. In mammals there are at least five S1P receptors (S1pr1-
5) [19]. Some of the S1P receptors are expressed in the nervous
system [20,21] and play a role in the development of neurons and
glia cells. S1pr1, for example, is necessary for brain development
[22] and the survival of oligodendrocyte precursors requires the
activity of S1pr5 [23]. However, S1P can also act as a second
messenger inside cells and elicit various cellular responses [24,25].
In addition to mobilizing intracellular Ca
2+ [24], recent studies
reported that intracellular S1P could regulate histone deacetylases
and the ubiquitin ligase activity of tumor necrosis factor receptor-
associated factor 2 [10,26,27]. Here, we demonstrate a role for the
S1P pathway in sensory ganglion development and show that
complete loss of Sphk activity leads to severe disruption of neuronal
survival and proliferation of progenitor cells in the developing
trigeminal and dorsal root ganglia.
Materials and Methods
Ethics statement
All studies using mice were conducted according to Institutional
Animal Care and Use Committee (IACUC) guidelines of the
Medical College of Wisconsin with approval, protocol AUA198.
Mice were housed and maintained in the Bioresource Center of
the Medical College of Wisconsin, which is accredited by the
Association for the Assessment and Accreditation of Laboratory
Animal Care (AAALAC).
Animals and genotyping
Sphk1, Sphk2, S1pr1, and S1pr2 mutant mice were generated and
characterized as described [22,28,29,30]. Double mutant mice
were generated by intercrossing Sphk12/2;Sphk2+/2 mice.
Genotyping by PCR was carried out as described [20].
Whole mount in situ hybridizations
E9.5 (22–25 somites) and E10.5 (32–35 somites) wild type,
Sphk12/2; Sphk2+/2 Sphk12/2; Sphk22/2 embryos were fixed
in 4% paraformaldehyde overnight at 4uC, rinsed in phosphate
buffered saline, and dehydrated in methanol series and stored in
100% methanol at 220uC. Embryos were processed for whole
mount in situ hybridization as previously described [31] and color
reaction developed with BM Purple (Roche). Whole mount and
section in situ hybridizations for each probe were repeated at least
three times to confirm our results.
Section in situ hybridization and immunfluorescence
For section in situ hybridizations, E10.5 (32–35 somites) and
E11.5 (40–42 somites) embryos were fixed with modified Carnoy’s
solution, processed for paraffin sectioning (10 mm), and in situ
hybridization as described [32]. For post-in situ immunohisto-
chemistry, slides were incubated in Tuj-1 or SOX10 overnight at
4uC [33]. Fluorochrome conjugated secondary antibodies (Jackson
ImmunoResearch) were applied for 2 hours at room temperature
in dark. Brightfield in situ hybridization and fluorescence
immunostaining signals on sections were photographed using a
Zeiss Z1 microscope equipped with a monochrome MRm
AxioCam camera. Brightfield signals were inverted in Adobe
Photoshop (from purple brightfield signal to green) and overlayed
with Tuj-1 and SOX10 fluorescence signals. For immunofluores-
cence, wild type, Sphk12/2; Sphk2+/2 Sphk12/2; Sphk22/2
embryos were embedded in gelatin, frozen in liquid nitrogen, and
stored in 280uC. Serial cryosections (10 mm) were cut from head
and trunk (between forelimb and hindlimb) regions of embryos
and adjacent sections were collected on two sets of slides. One set
of slides was stained for islet-1/2 and active-caspase 3 (act-Casp-3)
and the second set of slides was stained for SOX10 and phospho-
histone H3 (PH3).
Cell counting and statistics
All sections including trigeminal ganglia and dorsal root ganglia
(the first three DRG at the fore limb level) were photographed and
Tuj-1+, active-caspase 3+ (from one set of slides) and SOX10+,
phospho-histone H3+ (a second set of slides with alternate sections)
cells were counted using ImageJ. One trigeminal ganglion and two
DRG from each embryo were counted, and three embryos for
each group were used in the analyses. Data are expressed as means
6 standard error of means. Student’s t-test was used for statistics, p
values of p,0.01 or p,0.05 were considered significant.
Measurement of S1P, sphingosine and ceramide levels
Three E11.5 (40–42 somites) embryos from wild type, Sphk12/2;
Sphk2+/2, and Sphk12/2;S p h k 2 2/2 group were collected and
frozen immediately at 280uC. S1P, sphingosine, and ceramide
analyses were performed by the Lipidomics core of Medical
University of South Carolina. Data are expressed as means 6
standard error of means. Student’s t-test was used for statistics, p
values of p,0.01 or p,0.05 were considered significant.
Results
Sphingosine kinase 1 is expressed in the developing
trigeminal and dorsal root ganglia
We have previously shown that the developing sensory ganglia
express very low levels of S1P receptors during early gang-
liogenesis ([20] and data not shown). To investigate the potential
role of another key component in the S1P pathway, Sphingosine
kinase 1 (Sphk1), in the developing sensory ganglia, we first
examined its expression in these structures. We performed section
in situ hybridization on trigeminal and dorsal root ganglia sections
in E10.5 (32–35 somites) and E11.5 (40–42 somites) embryos.
At E10.5, Sphk1 transcript was scattered throughout the
trigeminal ganglion but was not expressed by all the cells
(Fig. 1A, B). To identify which cell types expressed Sphk1, we co-
labeled the same section with Tuj-1 and SOX10 to identify
neurons and neural crest progenitor cells, respectively. By
examining higher magnification of single labeled and merged
images, we found that Sphk1 was expressed in many SOX10+ cells
but not Tuj-1+ cells at this stage (Fig. 1C–F). At E11.5, Sphk1
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experiments showed that Sphk1 continued to be observed in
SOX10+ cells but now some neurons also began to express the
Sphk1 mRNA at E11.5 (Fig. 1G–L).
At E10.5, we detected Sphk1 in the periphery of the dorsal root
ganglia. Immunostaining with SOX10 in the same section
confirmed that Sphk1 co-localized with some SOX10+ cells,
suggesting that progenitor cells expressed Sphk1. We did not detect
Sphk1 transcripts in DRG neurons (Tuj-1+) at this stage (Fig. 2A–
F). At E11.5, we observed Sphk1 in the periphery of the DRG and
some scattered Sphk1+ cells were present throughout the ganglion.
Co-labeling experiments showed that Sphk1 was expressed in both
SOX10+ progenitors as well as Tuj-1+ neurons at this time
(Fig. 2G–L).
Depleting Sphingosine kinase activity causes defects in
sensory ganglia
To investigate the possible roles of Sphk1 in the developing
nervous system, we aimed to ablate Sphk1 in the mouse embryo. In
mammals, there are two Sphingosine kinases, Sphk1 and Sphk2,
and knockout mice for both have been generated [20,22].
Sphk12/2 or Sphk22/2 single mutants do not show any obvious
phenotype, survive until adulthood, and are fertile [22,28].
Previous studies demonstrated that Sphk2 mRNA levels were not
altered in Sphk1 null animals compare to controls. Furthermore,
S1P levels were found to be similar or just slightly decreased in
Sphk12/2 tissues compared to wild type [28]. As we do not
observe any sensory ganglia defects in the Sphk1 single mutant (Fig.
S2), Sphk2 may be able to compensate for the absence of Sphk1 by
maintaining sufficient S1P albeit it is expressed at low levels in
sensory ganglia (Fig. S1).
In contrast to Sphk1 or Sphk2 single mutant, Sphk1/2 double
knockout mice have severe phenotypes [22,28]. Deleting both Sphk1
and Sphk2 eliminates S1P function, and because S1P is important for
vascular development, Sphk12/2;Sphk22/2 embryos die at E12.5
due to vascular defects [22]. We generated Sphk12/2;Sphk22/2
double mutant embryos in order to examine the role of sphingosine
kinase activity in sensory ganglia development. Similar published
results, we observed that Sphk12/2;Sphk22/2 double mutant mice
die at E12-12.5 and the embryos are slightly smaller than their
littermates and wild type embryos [22]. We examined trigeminal and
dorsal root ganglia in Sphk12/2;Sphk22/2 double mutant embryos
at E11.5 (40–42 somites)and compared them to controls. In wild type
and Sphk12/2;Sphk2+/2 animals, trigeminal and dorsal root
ganglia were formed properly and the morphology of neurons was
normal, as demonstrated by Tuj-1 immuostaining. In contrast,
Sphk12/2;Sphk22/2 sensory ganglia appeared smaller and disor-
ganized (Fig. 3A–F). There appeared to be fewer Tuj-1+ neurons in
both trigeminal and dorsal root ganglia in Sphk12/2;Sphk22/2
embryos. These defects will be analyzed in more details and
presented in the following sections of the manuscript.
Figure 1. Sphk1 expression in the developing trigeminal ganglion. Sphk1 transcript was detected by section in situ hybridization followed by
Tuj1 and SOX10, immunostaining. (A–F) Sphk1 expression in E10.5 (32–35 somites) trigeminal ganglion. (A) Sphk1 mRNA (purple) can be observed
in the trigeminal ganglion and hindbrain (HB). (B) The same section in (A) was processed for Tuj-1 (green) and SOX10 (red) immunostaining. (C–F)
Enlarged image of boxed area in A and B. (C) Sphk1 (purple) is not expressed in all cells in the trigeminal ganglion. (D–F) Co-staining with Tuj-1
(green) and SOX10 (red) reveals that Sphk1 can be seen in Sox10+ progenitor cells (arrowhead) but not Tuj1+ neurons at E10.5. (E, F), Sphk1 signal
was pseudo-colored as green, Tuj1 and SOX10 immunostaining as red. Sphk1 signals are not found in Tuj-1+ neurons (arrowhead). Sphk1 signal
(green) co-localized with SOX10+ cells (arrowhead).( G–L) Sphk1 expression in E11.5 (40–42 somites) trigeminal ganglion. (G) Sphk1 (purple)
expression persists in E11.5 trigeminal ganglion. (H) The same section in (G) was processed for Tuj-1 (green) and SOX10 (red) immunostaining. (I–L)
Enlarged imaged of boxed area in G and H. (I, J) Sphk1 (purple) is expressed in a subpopulation of cells in the trigeminal ganglion. Sphk1 can be
observed in SOX10+ cells (arrowhead). Some neurons (Tuj1+, green) also express Sphk1 at this stage (arrow).( K,L) Sphk1 in situ signal was
pseudo-colored green, Tuj1 and SOX10 reactivity as red to observe overlap of in situ and immuostaining signals. Sphk1 mRNA (green) can be
detected in some neurons at E11.5 trigeminal ganglion (arrow). A subset of SOX10+ cells express Sphk1 (arrowhead). HB=hindbrain. Scalebar for
A, B=200 mm; scalebar for C–F=50 mm; scalebar for G, H=100 mm; scalebar for I–L=50 mm.
doi:10.1371/journal.pone.0027150.g001
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root ganglia [1]. To dissect the basis of sensory ganglia dysgenesis in
Sphk12/2;Sphk22/2 animals, we first compared the migration
pattern of neural crest cells in control and Sphk12/2;Sphk22/2
embryos using Sox10 whole mount in situ hybridization. E9.5 (22–
25 somitets) and E10.5 (32–35 somites) wild type,
Sphk12/2;Sphk2+/2 and Sphk12/2;Sphk22/2 embryos were
processed and compared together. At E9.5, the forming trigeminal
ganglion and hindbrain neural crest cells can be visualized in the
head. In the trunk, neural crest cells are beginning to migrate at the
level of the first few somites. Migrating neural crest cells and
trigeminal ganglia could be observed in E9.5 embryo in all three
genotypes (Fig. 4A–C). Although the Sphk12/2;Sphk22/2
embryos were slightly smaller, both cranial and trunk neural crest
cells showed normal migratory patterns. By E10.5, the trigeminal
ganglion is clearly formed and most of the trunk neural crest cells
are migrating. The pattern of migration of neural crest cells did not
seem to be altered in Sphk12/2; Sphk22/2; however, the streams
of migrating cells appeared to be thinner compare to controls
(Fig. 4D–F). Thus, neural crestformationandmigration occurredin
Sphk12/2;Sphk22/2 mutant embryos and the defects observed in
the sensory ganglia might take place shortly after their formation.
Ablation of Sphingosine kinases disrupted trigeminal
ganglion development
Because Sphk12/2;Sphk22/2 trigeminal ganglia appeared
smaller and might contain fewer cells at E10.5 (Fig. 3D–F), we
carried out a series of double immunostaining experiments at this
embryonic stage and quantitatively studied different cell popula-
tions, together with cell death, and cell proliferation assays. First,
we assessed cell death/apoptosis. We used anti-activated caspase
3+ (act-Casp3) and anti-Islet-1/2 antibodies to determine the
number of dying cells and neurons, respectively. In wild type
ganglia, there were a small number of act-Casp3+ cells as expected
due to naturally occurring cell death at this age. When we compared
the number of dying cells in wild type, Sphk12/2;Sphk2+/2,a n d
Sphk12/2;Sphk22/2trigeminal ganglia, there was a slight increase in
ce l ld e at hi nth eSphk12/2;Sphk2+/2and double mutants (Fig.5A–C,
H, Table 1). Next, we assessed cell proliferation. We examined the
number of mitotic cells and progenitor cells by using phosphohistone
H 3( P H 3 )a n dS O X 1 0a sm a r k e r s .W ef o u n dt h a tt h e r ew e r e3 3 4 618
dividing cells in wild type and 33169i nSphk12/2;Sphk2+/2,w h i l e
Sphk12/2;Sphk22/2 trigeminal ganglia only contained 263621
PH3+ cells (Fig. 5D–F). Some of the PH3+ cells also co-labeled with
SOX10 (Fig. 5D, E). Although the number of PH3+ cells was lower
(263621) in Sphk12/2;Sphk22/2 compared to controls (,331), the
percentage of dividing cells compared to the total number of cells in the
ganglia was essentially the same amongst these genotypes (,2.5% on
average, Table 1).
To determine if depleting Sphingosine kinases affected both neurons
and progenitor cells, we counted the total number of islet-1/2+
neurons and SOX10+ progenitors cells in the trigeminal ganglia at
E10.5. In wild type and Sphk12/2;Sphk2+/2 trigeminal ganglia,
there were 6,018 and 6,302 Islet-1/2+ neurons, respectively;
Figure 2. Sphk1 expression in the developing dorsal root ganglion. Sphk1 transcript was detected by section in situ hybridization followed
by Tuj1 and SOX10 immunostaining. (A–F) Sphk1 expression in E10.5 (32–35 somites) dorsal root ganglion. (A) Sphk1 in situ signal (purple) can be
detected in some cells in the dorsal root ganglion at this stage (DRG outlined by grey dots).( B) The same section in A processed for Tuj-1 (red)
and SOX10 (green) immunofluorescence. Most of the SOX10+ neural crest progenitor cells are found at the periphery and cap region of the ganglion
while Tuj1+ neurons are more centrally located. (C–F) Enlarged image of boxed area in A and B. (C,D) Sphk1 transcript is primarily located in the
periphery of the DRG and co-incides with the occurrence of SOX10+ cells (arrowhead).( E,F) In these panels, Sphk1 in situ signal is pseudo-colored
green, Tuj-1 (red, E) and SOX10 (red, F) to visualize co-localization. Sphk1 mRNA is associated with SOX10+ cells (arrowheads); Tuj1+ neurons do not
express Sphk1 at this time. (G–L) Sphk1 expression in E11.5 (40–42 somites) dorsal root ganglion. (G) Sphk1 signal (purple) is seen mostly in the cap
region of the ganglion (DRG outlined by grey dots).( H) Same section in G immunostained with Tuj1 (green) and SOX10 (red). Majority of the
SOX10+ cells (red) are located in the periphery and cap region of the DRG but several SOX10+ cells can also be found in the central region. (I–L)
Enlarged image of boxed area in G and H. (I,J) Similar to E10.5, many SOX10+ cells express Sphk1 (arrowhead) but some neurons (arrow) also
express Sphk1 at E11.5. (K,L) Sphk1 signal is pseudo-colored green and Tuj1 red (K), SOX10 red (L) to confirm co-localization of signals. Sphk1 mRNA is
found in SOX10+ cells (arrowhead), cells that are Sphk1+/SOX10+ appear yellow in L. Some neurons express Sphk1 at this time (arrow). NT=neural
tube. Scalebar for A, B and G, H=50 mm; scalebar for C–F and I–L=20 mm.
doi:10.1371/journal.pone.0027150.g002
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decrease compared totheothertwogenotypes (Fig.5A,G, Table 1).
We also observed a significant decrease (26%) in the progenitor
population. Sphk1/2 double mutant ganglia had only 5,373
SOX10+ cells compared to 7,252 in wild type and 7,245 in
Sphk12/2;Sphk2+/2. However, because neither cell proliferation
nor cell death was greatly affected in the double mutant trigeminal
ganglia at E10.5, it is possible that the reduced number of neurons
and progenitors was caused by a decrease in neuronal differenti-
ation and/or a scarcity of progenitor cells.
Survival of trigeminal ganglion cells was compromised by the
loss of Sphk activity as an increase in cell death was observed at
E11.5. We performed cell death and proliferation analyses on
E11.5 trigeminal ganglia and quantified cell numbers. In wild type
and Sphk12/2;Sphk2+/2 trigeminal ganglia, only 0.3–0.8% (61–
152 act-casp3+ cells out of 18,899–19,755 total cells) of all cells
were dying; on the other hand, there were significantly more act-
casp3+ cells throughout the Sphk12/2;Sphk22/2 double mutant
ganglia (23436369, 19.5% of total cells; Table 1, Fig. 6A–C, H).
In addition, the number of dividing cells was greatly reduced in
Sphk12/2;Sphk22/2 compared to control embryos (Fig. 6D–F,
H). In Sphk1/Sphk2 double mutants, there were only 1764 PH3+
cells compared to 397611 in wild type and 402634 in
Sphk12/2;Sphk2+/2 trigeminal ganglia. When we counted the
total number of neurons and progenitor cells, we found that wild
type and Sphk12/2;Sphk2+/2 trigeminal ganglia had an average
of 10,000 neurons whereas Sphk12/2;Sphk22/2 had about
5,531 (Table 1). The number of SOX10+ progenitors was also
significantly lower. While wild type and Sphk12/2;Sphk2+/2
ganglia had an average of 9,500 SOX10+ cells, the double mutant
only had ,6,463 such cells. Thus, both neurons and non-neuronal
cells showed a 35–40% loss in cell number when Sphk1 and Sphk2
were deleted. Survival of both neurons and progenitor cells were
affected by the absence of Sphks as act-casp3+ cells were found in
both islet-1/2+ and SOX10+ populations (Fig. S3).
Deleting Sphks negatively influenced dorsal root
ganglion development
Next we examined if the spinal sensory ganglia defects were
similar to those observed in the trigeminal ganglia. At E10.5, there
were few act-Casp3+ cells (Fig. 7A–C, H) and only several PH3+
cells (Fig. 7D–F, H) in dorsal root ganglia from all genotypes.
Although the number of SOX10+ cells in Sphk12/2;Sphk22/2
was slightly lower compared to wild type and Sphk12/2;
Sphk2+/2 dorsal root ganglia, the difference was not significant.
Some PH3+ were dually positive for SOX10 (Fig. 7D–F, G). Even
without major changes in cell death and proliferation, the double
mutant DRG were still significantly smaller in size and there
appeared to be fewer islet-1/2+ cells. Indeed when we counted the
neurons, we found that there were ,328 islet-1/2+ neurons in the
Figure 3. Sensory ganglia in Sphk12/2;Sphk22/2 embryos
appear disorganized and smaller. Head and trunk transverse
sections from E11.5 (40–42 somites) wild type, Sphk12/2;Sphk2+/2,
and Sphk12/2;Sphk22/2 mice were processed for Tuj1 (red) immuno-
fluorescence and counterstained with DAPI (blue) to examine morphol-
ogies of the trigeminal (Trig) and dorsal root ganglia (DRG).( A–C) Trunk
sections showing E11.5 DRG in wild type, Sphk12/2;Sphk2+/2,a n d
Sphk12/2;Sphk22/2 embryos. (A,B) DRG from wild type and
Sphk12/2;Sphk2+/2 are similar in shape, size, and Tuj1+ neurons look
normal. (C) In contrast, Sphk12/2;Sphk22/2 DRG has a less well-defined
shape and there appear to be fewer neurons. (D–F) Sections showing
trigeminal ganglia from wild type, Sphk12/2;Sphk2+/2,a n d
Sphk12/2;Sphk22/2 embryos. (D,E) Trigeminal ganglia from wild type
and Sphk12/2;Sphk2+/2 are similar in shape, size, and contain many
Tuj1+ neurons. (F) Sphk12/2;Sphk22/2 trigeminal ganglion is smaller
and may have fewer neurons. NT=neural tube. Scalebar for A–
C=50mm; scalebar for D–F=100 mm.
doi:10.1371/journal.pone.0027150.g003
Figure 4. Deleting Sphk1 and Sphk2 does not alter neural crest
migration pattern. Sox10 whole mount in situ hybridization was
p e r f o r m e do nw i l dt y p e ,Sphk12/2;Sphk2+/2,a n dSphk12/2;Sphk22/2
embryos at E9.5 (22–25 somites) and E10.5 (32–35 somites). (A–C)A tE 9 . 5 ,
Sox10 expression can be detected in the forming trigeminal ganglia
(arrow), hindbrain neural crest (asterisk) as well as the developing ear
(e).Trunkneuralcrestcellsarebeginningtomigrateinthefirstfewsomites
(arrowhead). Embryos from all three genotypes show similar Sox10
staining pattern even though the Sphk12/2;Sphk22/2 embryo is slightly
smaller (C). (D–F) At E10.5, trunk neural crest migration (arrowhead) is
well underway and can be visualized by Sox10 staining. Trigeminal ganglia
(arrow) andhindbrain neural crestcells (asterisk) canbeidentifiedatthis
stage. Sox10+ neural crest cells are present in the Sphk12/2;Sphk22/2
embryo and they display the stereotypical segmental migration pattern
similar tothe wild type embryo although the stream of neural crest cells in
Sphk12/2;Sphk22/2 double mutant embryo appears narrower compar-
ing to wild type and Sphk12/2;Sphk2+/2 embryos. The ear (e) continues
to express Sox10. Scalebars for A–C and D–F=500 mm.
doi:10.1371/journal.pone.0027150.g004
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controls (Fig. 7A–C, G; Table 1). Thus, the double mutant DRG
had less than half the number of neurons compare to controls,
suggesting that the lack of Sphk activity negatively influenced
neuronal differentiation or survival or both of these events during
the initial formation of the DRG.
By E11.5, cell death and proliferation were affected in
Sphk12/2;Sphk22/2 mutant DRG. At this stage, there were
only a small number of dying cells in wild type and Sphk12/2;
Sphk2+/2 ganglia, as normal cell death has not commenced [34].
On the other hand, many more act-Casp3+ cells were detected in
the double mutant DRG (156631; Table 1; Fig. 8A–C, H).
Quantification showed that E11.5 Sphk12/2;Sphk22/2 dorsal
root ganglia had ,156 act-Casp3+ compared to 9 in wild type
and 17 in Sphk12/2;Sphk2+/2 embryos. Mitotic activity in
normal dorsal root ganglia was modest at E11.5. We saw 26–36
PH3+ in wild type and Sphk12/2;Sphk2+/2 DRG and some
PH3+ were also SOX10+. In the double mutant ganglia, even
fewer PH3+ could be detected (465P H 3 + on average; Table 1;
Fig. 8D–F, H).
Figure 5. Loss of neurons and progenitor cells can be observed in E10.5 trigeminal ganglion in the Sphk12/2;Sphk22/2 double
mutant. (A–C) Trigeminal ganglion sections from wild type, Sphk12/2;Sphk2+/2, and Sphk12/2;Sphk22/2 were processed for activated Caspase 3
(red, act-Casp-3) and islet-1/2 (green, nuclear) immunofluorescence to identify dying cells and neurons, respectively. There are very few act-Casp-
3+ cells in the wild type (A) trigeminal ganglion at E10.5 (32–35 somites). In comparison, both Sphk12/2;Sphk2+/2 (B), and Sphk12/2;Sphk22/2 (C)
trigeminal ganglia have a small but significant increase in act-Casp-3+ cells (arrowhead in B,C; black bars in H). Sphk12/2;Sphk22/2 trigeminal
ganglia are smaller and contain fewer islet-1/2 positive neurons compare to wild type and Sphk12/2;Sphk2+/2 ganglia (A–C; black bars in G).
(D–F) Adjacent sections from those used in (A–C) were immunostained for phosphoshistone H3 (PH3, red) and SOX10 (green, nuclear) to identify
dividing cells and neural crest progenitors, respectively. (D–F) PH3+ cells can be found throughout the trigeminal ganglia in all three genotypes
examined and some PH3+ are dually positive for SOX10 (white arrowheads in D–F). There are fewer PH3+ and SOX10+ cells in Sphk12/2;
Sphk22/2 trigeminal ganglion (F; grey bars in G,H). (G) Quantification of the total number of islet-1/2+ (neurons, black bars) and SOX10+
(progenitor cells, grey bars) cells reveals that while the number of neurons and progenitor cells are similar in E10.5 wild type and
Sphk12/2;Sphk2+/2 trigeminal ganglia, both islet-1/2+ and SOX10+ cells are significantly reduced in Sphk12/2;Sphk22/2. n=3 embryos from each
genotype; *=Sphk12/2;Sphk22/2 to wild type comparison, p,0.05; {=Sphk12/2;Sphk22/2 to Sphk12/2;Sphk2+/2 comparison, p,0.05;
{{=Sphk12/2;Sphk22/2 to Sphk12/2;Sphk2+/2 comparison, p,0.01. (H) Quantification of the total dying (act-Casp-3+, black bars) and
dividing (PH3+, grey bars) cells confirms that there is very little cell death in E10.5 wild type trigeminal ganglion. A small but significant increase in
the number of dying cells can be seen in Sphk12/2;Sphk2+/2 and Sphk12/2;Sphk22/2 double mutant compared to the wild type. n=3 embryos
from each genotype; *=Sphk12/2; Sphk22/2 to wild type comparison, p,0.05;
#=Sphk12/2;Sphk2+/2 to wild type comparison, p,0.05;
{=Sphk12/2;Sphk22/2 compare with Sphk12/2;Sphk2+/2,p ,0.05. Scalebar for A–F=100 mm.
doi:10.1371/journal.pone.0027150.g005
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theabsenceofSphks.Wildtype and Sphk12/2;Sphk2+/2DRGhad
an average of ,1,100 neurons while Sphk12/2;Sphk22/2 double
mutant ganglia had ,770, representing a 32% loss in neurons. The
decrease in SOX10+ cells was about ,33% in the double mutant
(544 SOX10+ cells) compared to controls (818 and 795 SOX10+
cells in wild type and Sphk12/2;Sphk2+/2 embryos, respectively).
Deficits in sensory ganglia development can be
attributed to the loss of Sphingosine kinase activity
Many effects of the S1P pathway are mediated through S1P
receptors. In the Sphk12/2;Sphk22/2 embryos, cell death and
proliferation were affected in the brain at E11.5. The developing
brain expresses abundant S1pr1 [20,22], and cell death and
proliferation defects were obvious at E11.5 in S1pr1 null animals
[20]. These data suggested that perhaps S1P, acting through
S1pr1, was at least partially responsible for CNS development.
Besides the receptor-mediated activities of S1P, our data support a
role for the intracellular activity of SPHK in regulating sensory
ganglia development. To begin to address this issue, we compared
trigeminal and dorsal root ganglia from S1pr1 and S1pr2 mutant
mice [29,30,35] and Sphk1;Sphk2 double knockout embryos. While
S1pr22/2 mouse do not display overt neural phenotypes until
three to seven weeks of age [30], S1pr12/2 embryos die between
E12.5–E14.5 due to embryonic hemorrhage [29]. In contrast to
Table 1. Quantification of cell numbers in control and Sphk12/2;Sphk22/2 sensory ganglia.
E10.5 Trigeminal ganglia
Wild type Sphk12/2; Sphk2+/2 Sphk12/2; Sphk22/2 % Reduction
Neurons (islet-1+) 60186535 63026858 41136414 32
precursors (SOX10+) 72526718 72456330 53736330 26
total cells 1327061242 1354761188 94856744 29
Active-caspase3+ 1966 100633 87625
PH3+ 334618 331692 6 3 621
% of dying cells 0.1 0.7 0.9
% of mitotic cells 2.5 2.4 2.8
E11.5 Trigeminal ganglia
Wild type Sphk12/2; Sphk2+/2 Sphk12/2; Sphk22/2 % Reduction
Neurons (islet-1+) 94356411 101486719 55316887 41
precursors (SOX10+) 94646513 96076244 64636664 32
total cells 188996924 197556963 1199461551 37
Active-caspase3+ 61614 152619 23436369
PH3+ 397611 402634 17614
% of dying cells 0.3 0.8 19.5
% of mitotic cells 2.1 2 0.1
E10.5 Dorsal root ganglia
Wild type Sphk12/2; Sphk2+/2 Sphk12/2; Sphk22/2 % Reduction
Neurons (islet-1+)7 5 4 675 762640 328675 6
precursors (SOX10+)5 0 0 657 423621 379628 24
total cells 12546131 1185628 707626 44
Active-caspase3+ 0.6760.20 1.0060.70 0.1760.20
PH3+ 28622 6 622 5 63
% of dying cells 0 0 0
% of mitotic cells 2.2 2.2 3.5
E11.5 Dorsal root ganglia
Wild type Sphk12/2; Sphk2+/2 Sphk12/2; Sphk22/2 % Reduction
Neurons (islet-1+) 1137688 1058625 770624 32
precursors (SOX10+)8 1 8 642 795647 544620 33
total cells 1955685 1853664 1315643 33
Active-caspase3+ 9651 7 671 5 6 631
PH3+ 26663 6 654 65
% of dying cells 0.4 0.9 11.9
% of mitotic cells 1.3 1.9 0.3
doi:10.1371/journal.pone.0027150.t001
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which were much reduced in size and cell number, S1pr1 and
S1pr2 null sensory ganglia were similar to their control littermates
(Fig. 9 and data not shown).
To investigate if the effects of ablating Sphks were specific to
sensory ganglia, we examined the sympathetic ganglia, which
are also neural crest derived. At E11.5, Sphk1 transcript was
not detected in the sympathetic ganglia (Fig. 10). When we
compared wild type, Sphk12/2;Sphk2+/2,a n dSphk12/2;
Sphk22/2 embryos, sympathetic ganglia appeared normal in
all three genotypes (Fig. 10). This suggests that deleting Sphks
did not impose non-specific defects in all periphery
ganglia.
Ablation of Sphk perturbed sphingolipid balance in the
embryo
How does the absence of Sphks cause such catastrophic cell loss
in the sensory ganglia? Sphingosine-1-phosphate (S1P) is formed
by the phosphorylation of sphingosine by SPHK1 or SPHK2.
Genetic deletion of both Sphks renders an animal with essentially
no S1P [22], Table 2. One possible explanation for the cell death
and proliferation phenotypes that we observe is that S1P usually
stimulates cell growth; thus, its depletion can lead to a decrease in
cell division. Moreover, with the accumulation of sphingosine due
to the lack of SPHK activity, it is plausible that this substrate can
be fed into the other end of the pathway and increases the level of
ceramide, which favors cell death (Fig. 11). To test this idea, we
Figure 6. Cell loss is further exacerbated in E11.5 Sphk12/2;Sphk22/2 trigeminal ganglion. (A–C) E11.5 (40–42 somites) trigeminal
ganglia from wild type, Sphk12/2;Sphk2+/2, and Sphk12/2;Sphk22/2 were immunostained with antibodies to act-Casp-3 (red, arrowhead) and
islet-1/2 (green, nuclear). A small number of act-Casp-3+ cells can be seen in wild type and Sphk12/2;Sphk2+/2 ganglia; in contrast, there are
many more act-Casp-3+ cells in Sphk12/2;Sphk22/2 trigeminal ganglion. (D–F) Adjacent sections to those in (A–C) were immunostained with
antibodies to PH3 (red, arrow) and SOX10 (green, nuclear). PH3+ cells are scattered throughout the trigeminal ganglia from wild type (D) and
Sphk12/2;Sphk2+/2 (E) embryos. (F) There are very few PH3+ cells in the Sphk12/2;Sphk22/2 trigeminal ganglia; normal number of PH3+ cells
outside the trigeminal ganglion were detected in the double mutant (asterisks).( G) Quantification of total cell number shows that the number of
neurons (islet-1/2+) and progenitor cells (SOX10+) are similar in the wild type and Sphk12/2;Sphk2+/2 at E11.5. There are significant decreases in
neurons and progenitor cells in Sphk12/2;Sphk22/2 double mutant ganglia. n=3 embryos from each genotype; **=Sphk12/2;Sphk22/2 to wild
type comparison, p,0.01.
{{=Sphk12/2;Sphk22/2 to Sphk12/2;Sphk2+/2 comparison, p,0.01. (H) Compare to wild type, the increase of act-
Casp-3+ dying cells is small and represents less than 1% of the total cell population in the Sphk12/2;Sphk2+/2 trigeminal ganglia, the number of
dying cells increases to 2,343, almost 20% of the total cells in Sphk12/2;Sphk22/2 double mutant trigeminal ganglia. We observe significant
decrease of PH3+ dividing cells in the double mutant compare to wild type and Sphk12/2;Sphk2+/2 trigeminal ganglia at this stage.
**=Sphk12/2;Sphk22/2 to wild type comparison, p,0.01.
{{=Sphk12/2;Sphk22/2 to Sphk12/2;Sphk2+/2 comparison, p,0.01;
##=Sphk12/2;Sphk2+/2 to wild type comparison, p,0.01. Scalebar for A–F=100 mm.
doi:10.1371/journal.pone.0027150.g006
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Sphk22/2 embryos at E11.5 and measured their S1P and
sphingolipid levels. As expected, there was little to no S1P in
double mutant embryos that was above background level. In
Sphk12/2;Sphk2+/2, S1P level was reduced compared to wild
type, which was also anticipated and had been reported previously
[22], Table 2). To our surprise, sphingosine levels did not differ
significantly in wild type, Sphk12/2;Sphk2+/2, and Sphk12/2;
Sphk22/2 embryos, and ceramide level in Sphk12/2;Sphk22/2
embryos was 50% and Sphk12/2;Sphk2+/2 65% of wild type
(Table 2).
When we examined the data in more detail, we found that the
sphingolipid levels were decreased across the board and S1P was
absent in the double mutant. The balance of ceramide/S1P has
been proposed as a ‘‘rheostat’’ to regulate cell growth and cell
death [17,18,36]. Thus, we compared the relative ratios of
ceramide/S1P and Sph/S1P in control and Sphk12/2;Sphk22/2
animals. In wild type, the ratio of ceramide/S1P ratio was 28.2
and Sph/S1P was 3.4. In Sphk12/2;Sphk2+/2 embryos,
ceramide/S1P and Sph/S1P ratios were elevated to 78.5 and
13.6, respectively. Because there was almost no S1P in the
Sphk12/2;Sphk22/2 double mutant, the ceramide to S1P ratio
sharply increased to 2,263.70 and Sph/S1P to 377.9 (Table 2).
Discussion
We have investigated the role of Sphk1, a key component in S1P
signaling, in the developing sensory ganglia. We found that Sphk1
was expressed first in neural crest progenitors then neurons in
newly formed trigeminal and dorsal root ganglia. To investigate its
function during development, we generated Sphk1/Sphk2 double
mutant mice that completely lacked Sphk activity. Absence of Sphks
leads to massive cell death in neurons and progenitors as well as
near complete suppression of cell proliferation in the progenitor
population. The Sphk1 and Sphk2 double knockout results showed
that the phenotypes in the trigeminal and dorsal root ganglia are
robust at E11.5—both neurons and progenitor cells are greatly
depleted due to a combination of an increase in cell death and a
decrease in cell proliferation. Upon examination of sphingolipid
levels in the Sphk mutant, we saw an overall decline in multiple
sphingolipids and essentially no S1P. Our data provide strong in
vivo evidence that sphingosine kinase/S1P signaling has a novel
role in regulating cell survival during development of sensory
ganglia. Establishment of the sensory ganglia involves proper
migration and condensation of neural crest stem cells, differenti-
ation, and cell proliferation. In the Sphk1/2 double mutant, we did
not observe overt disruption of neural crest migration pattern,
Figure 7. Ablation of Sphk1 and Sphk2 affects neuron but not progenitor cell numbers in E10.5 dorsal root ganglion. (A–C) Transverse
trunk sections from wild type, Sphk12/2;Sphk2+/2, and Sphk12/2;Sphk22/2 immunostained with islet-1/2 (green, nuclear) and act-Casp-3 (red).
Wild type (A) and Sphk12/2;Sphk2+/2 (B) DRG appear similar in shape and size. Sphk12/2;Sphk22/2 DRG (C) is smaller and has fewer neurons.
Few act-Casp-3+ cells are observed in DRG from all three genotypes. (D–F) Adjacent sections to those used in (A–C) were processed for PH3 (red)
and SOX10 (green, nuclear) immunofluorescence. The shapes of the DRG are similar in wild type (D) and Sphk12/2;Sphk2+/2 (E); most SOX10+
cells are located in the periphery of the ganglion. Sox10+ cells in Sphk12/2;Sphk22/2 DRG are no longer restricted to the periphery of the ganglion.
PH3+ (green) cells can be found in DRG from all genotypes examined and some of them are also SOX10 positive (arrow).( G) Quantification of cell
number in E10.5 DRG demonstrates that there are 24% fewer SOX10+ cells in Sphk12/2;Sphk22/2 DRG compared to wild type and
Sphk12/2;Sphk2+/2 but this reduction is not statistically significant (p=0.079). The double mutant DRG shows a 56% reduction in the number of
neurons compared to wild type and Sphk12/2;Sphk2+/2 embryos. n=3 embryos from each genotype; ** =Sphk12/2;Sphk22/2 to wild type
comparison, p ,0.01.
{{ =Sphk12/2;Sphk22/2 to Sphk12/2;Sphk2+/2 comparison, p,0.01. (H) Quantification of total number of dying (act-
Casp-3+) and dividing (PH3+) cells. Cell count results reveal no significant difference in cell death and proliferation in Sphk12/2;Sphk22/2 DRG
compared to wild type and Sphk12/2;Sphk2+/2 at this stage. NT=neural tube. Scalebar for A–F= 50 mm.
doi:10.1371/journal.pone.0027150.g007
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that depleting S1P in the embryo does not affect neural crest cell
formation and migration per se but may affect their survival and/
or proliferation.
Although the actions of S1P are usually transmitted through
binding to its receptors, the sensory ganglia phenotype observed
here could be explained at least in part, by SPHK activities. In
contrast to the massive defects we observed in Sphk12/2;Sphk22/
Figure 8. Cell loss in Sphk12/2;Sphk22/2 becomes apparent in the dorsal root ganglia by E11.5. (A–C) E11.5 DRG section from wild type,
Sphk12/2;Sphk2+/2, and Sphk12/2;Sphk22/2 embryos immunostained with antibodies to act-Casp-3 (red) and islet-1/2 (green, nuclear). Very
few act-Casp-3+ cells can be observed in wild type (A) and Sphk12/2;Sphk2+/2 (B) while Sphk12/2;Sphk22/2 (C) shows significant cell death
(arrowhead).( D–F) Adjacent sections to those in (A–C) were stained with anti-PH3 (red) and SOX10 (green). Both wild type (D) and
Sphk12/2;Sphk2+/2 (E) DRG display PH3+ cells and some of them are also SOX10+ (arrow). Sphk12/2;Sphk22/2 DRG (F) is smaller and has fewer
PH3+ cells (red).( G) Quantification of total cell number shows that Sphk12/2;Sphk22/2 DRG have significant loss (.30%) in both neurons (black
bars) and progenitor cells compare to wild type and Sphk12/2;Sphk2+/2. n=3 embryos from each genotype; **=Sphk12/2; Sphk22/2 to wild
type comparison, p,0.01.
{{=Sphk12/2; Sphk22/2 to Sphk12/2;Sphk2+/2 comparison, p,0.01. (H) Wild type and Sphk12/2;Sphk2+/2 DRG have
fewer than 20 act-Casp-3+ dying cells on average but Sphk12/2;Sphk22/2 double mutants have an average of 156 dying cells. Cell proliferation is
modest in E11.5 wild type and Sphk12/2;Sphk2+/2 DRG but is further reduced in the double mutant. n=3 embryos from each genotype;
*=Sphk12/2;Sphk22/2 compare with wild type, p,0.05; **=Sphk12/2;Sphk22/2 to wild type comparison, p,0.01.
{{=Sphk12/2;Sphk22/2 to
Sphk12/2;Sphk2+/2 comparison, p,0.01. NT=neural tube. Scalebar for A–F=50 mm.
doi:10.1371/journal.pone.0027150.g008
Figure 9. Trigeminal ganglia develop normally in S1pr1 and S1pr2 mutant mice. E11.5 (40–42 somites) trigeminal ganglia were sectioned
processed for Tuj-1 immunostaining (brown), hematoxylin was used as a counterstain (blue).( A–C) Trigeminal ganglia from control, S1pr12/2 and
S1pr22/2 appeared similar in size and contain many Tuj-1+ neurons. (D) A section from Sphk12/2;Sphk22/2 trigeminal ganglion was included here
for comparison. It was much smaller compared to S1pr12/2 and S1pr22/2 trigeminal ganglia. Scalebar for A–D=100 mm.
doi:10.1371/journal.pone.0027150.g009
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largely similar to their heterozygous litters and wild type controls.
These data suggest that Sphk1 and intracellular S1P signaling can
play a role in sensory ganglia development.
Ceramide and sphingosine regulate stress response pathways
and usually induced cell death and growth arrest. On the other
hand, S1P tends to promote cell proliferation and inhibit cell
death. Thus, the balance of intracellular ceramide, sphingosine,
and S1P is important in regulating cell growth and survival
[17,18,36]. In the Sphk1/2 double mutant, there was essentially no
S1P. Hence, we hypothesized that the massive decrease in cell
survival of sensory ganglia lacking Sphks was caused by a large
increase in ceramide and sphingosine in the absence of S1P. When
we measured the levels of these sphingolipids, we found that there
was no S1P in the double mutant as expected. There was also a
four-fold decrease in S1P in Sphk12/2;Sphk2+/2 embryos
compared to wild type, which is also expected. Ceramide level
was decreased by 2-fold in Sphk12/2;Sphk22/2 double knockout
and there was a slight decrease in sphingosine. This was a bit
surprising as we expected a buildup of sphingosine due to the
absence of SPHK activity. We then considered the balance of
these sphingolipids and sought to examine if they were altered.
The ratio of ceramide:S1P was 28.2 in wild type and 78.5 in
Sphk12/2;Sphk2+/2 embryos; however, this ratio rose dramat-
ically to 2,263.7 in the double mutant due to the absence of S1P.
The sphingosine/S1P ratio was 3.4 in wild type and 377.8 in
Sphk12/2;Sphk22/2 mutants, over a 100-fold increase. There-
fore, although the pro-apoptotic ceramide and sphingosine were
not increased, the lack of S1P disrupted the sphingolipid balance
inside cells, favoring cell death and suppressing cell proliferation
and survival. Our current study demonstrates that the relative
ratios of these molecules are important in regulating cell survival in
vivo.
During sensory ganglia development, several signaling pathways
have been implicated in the survival and maintenance of neurons
and precursor cells. For example, the family of neurotrophins and
their receptors (Trk A, B, C) are involved in sensory neuron
survival in both trigeminal and dorsal root ganglia [2,5,37]. It is
unlikely that Sphk1 is directly downstream of Trk receptors because
it was clearly demonstrated that only neurons but not progenitor
cells express Trk receptors in murine sensory ganglia [2] whereas
Sphk1 is expressed in both cell populations. It is possible that the
p75 receptor pathway may indirectly influence Sphk1 activity as it
can activate ceramide and apoptotic pathways [38,39,40]. Sphk1 is
expressed by E10.5 in the sensory ganglia when p75 receptor can
be observed; thus, it is plausible that Sphk1 can act downstream of
Figure 10. E11.5 sympathetic ganglia express little to no Sphk1 and are not affected by the absence of Sphk1 and Sphk2. (A) E11.5 (40–
42 somites) mouse transverse sections including sympathetic ganglia were processed for Sphk1 in situ hybridization followed by Tuj1 (green) and
SOX10 (red) immunostaining. (A-a) Little Sphk1 transcript can be detected in E11.5 sympathetic ganglion (outlined by black dots).( A-b) Same
section in (A-a) labeled with Tuj1 (green) and SOX10 (red).( B) Transverse trunk sections from wild type, Sphk12/2;Sphk2+/2, and Sphk12/2;
Sphk22/2 processed for Tuj1 immunofluorescence (red), all nuclei were counterstained with DAPI (blue). (a–c) Sympathetic ganglia from all three
genotypes do not display any significant difference in size and morphology. Sym=sympathetic ganglia. Scalebar for A-a,b=30 mm. Scalebar for B-
a,b=30 mm.
doi:10.1371/journal.pone.0027150.g010
Table 2. Sphingolipid measurements in control and
Sphk12/2;Sphk22/2 embryos.
pomole/
sample Wild type
Sphk12/2;
Sphk2+/2
Sphk12/2;
Sphk22/2
S1P 5.9061.00 1.3960.14
## 0.0460.02**
{{
Sph 19.7962.44 18.9263.00 13.7762.70
ceramide 2164.146200.28 1420.94648.73
# 1072.376193.68**
fold change compared to Wild type embryo
S1P 1.0000 0.2359 0.0062
Sph 1.0000 0.9564 0.6959
Ceramide 1.0000 0.6566 0.4955
sphingolipid ratios
Ceramide/S1P 28.1923 78.4725 2,263.6738
Sph/S1P 3.3509 13.5862 377.8888
**p,0.01 Sphk12/2;Sphk22/2 compare to Wild type.
{{p,0.01 Sphk12/2;Sphk22/2 compare to Sphk12/2; Sphk2+/2.
#p,0.05 Sphk12/2;Sphk2+/2 compare to Wild type.
##p,0.01 Sphk12/2;Sphk2+/2 compare to Wild type.
doi:10.1371/journal.pone.0027150.t002
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addition to regulating cell death and proliferation in the
developing nervous system, S1P/Sphingosine kinase signaling
may modulate neuronal survival and functions in adult animals.
For instance, in an in vitro model of brain ischemia, S1P was
shown to reduce cell death, possibly via protein kinase C e
translocation to the mitochondria as well as reduction of Ca
2+ in
the mitochondria [41]. In adult hippocampal CA3 neurons,
synaptic localization and activation of S1PR3, and generation of
long-term potentiation were dependent on the production of S1P
by SPHK1, as these activities were completely abolished in Sphk1
null animals [42]. These data suggests that S1P/Sphingosine
kinase signaling exert wide-ranging effects in the nervous system,
some of which are receptor independent while others may require
interactions with S1P receptors.
In summary, we have shown that the complete absence of
Sphingosine kinase/S1P activity has a detrimental effect on early
sensory gangliogenesis—assigning a novel role for sphingosine
kinase in the developing nervous system. Our future goal is to
identify signaling pathways that interact with S1P and mediate the
proper formation of sensory ganglia.
Supporting Information
Figure S1 Sensory ganglia in Sphk12/2 and Sphk22/2
single knockout mice do not display any obvious defects.
Head and trunk transverse sections from E11.5 (40–42 somites)
wild type, Sphk12/2 and Sphk22/2 mice were processed for
Tuj1 (red) immunofluorescence and counterstained with DAPI
(blue) to examine morphologies of the trigeminal (Trig) and
dorsal root ganglia (DRG).( A,B) Trunk sections showing E11.5
DRG in Sphk12/2 and Sphk22/2 embryos. DRG from
Sphk12/2 (A) and Sphk22/2 (B) are similar in shape, size, and
contain many Tuj1+ neurons; they look similar to wild type and
Sphk12/2;Sphk2+/2 DRG in Fig. 3A–B. (C,D) Sections showing
trigeminal ganglia from Sphk12/2 and Sphk22/2 embryos.
Trigeminal ganglia from Sphk12/2 (C) and Sphk22/2 (D) are
similar in shape, size, and contain many Tuj1+ neurons; they look
similar to wild type and Sphk12/2;Sphk2+/2 trigeminal ganglia
in Fig. 3D–E. Scalebar for A, B=50 mm; scalebar for
C,D=100 mm.
(TIF)
Figure S2 Sphk2 expression in the developing sensory
ganglia. E10.5 (32–35 somites) and E11.5 (40–42 somites)
transverse sections were processed for Sphk2 (grey/black) section
in situ hybridization followed by Tuj1 (green) and SOX10 (red)
immunofluorescence. (A,B) E10.5 dorsal root ganglion (DRG).
(C,D) E10.5 trigeminal ganglion (Trig).( E,F) E11.5 dorsal root
ganglion (DRG).( G,H) E11.5 trigeminal ganglion (Trig). Sphk2
is expressed at low to undetectable level in E10.5-11.5 dorsal root
and trigeminal ganglia. NT=neural tube. Scalebar for A,B=50 mm;
scalebar for C,D=50 mm; scalebar for E,F=50 mm; scalebar for
G,H=50 mm.
(TIF)
Figure S3 Apoptosis can be detected in neurons and
progenitor cells in the Sphk12/2;Sphk22/2 sensory
ganglia. E11.5 (40–42 somites) trigeminal and dorsal root ganglia
from Sphk12/2;Sphk22/2 embryos were immunostained with
antibodies to SOX10 (green; A, C, E) and act-Casp-3 (red),o r
islet-1/2 (green; B, D, F) and act-Casp-3 (red).( A,B) Many act-
Casp-3+ cells can be observed in E11.5 double mutant trigeminal
ganglia. (C) High magnification images of boxed area in A. Some
act-Casp-3+ (red) cells are closely associated with SOX10+ cells
(arrow).( D )High magnification images of boxed area in B. Some
act-Casp-3+ (red) cells are also islet-1/2+ (arrowhead).( E,F)
Many act-Casp-3+ cells can be seen in E11.5 double mutant dorsal
root ganglia. (E) Some act-Casp-3+ cells are closely associated with
SOX10+ cells (arrow).( F) We can also observe act-casp-3+ cells
associated with islet-1/2+ nuclei (arrowhead). NT=neural
tube. Scalebar for A,B=50 mm; scalebar for C,D=50 mm;
scalebar for E,F=50 mm.
(TIF)
Figure 11. Schematic of S1P-SPHK1 and model of S1P-Sphingosine/ceramide balance. (A) A highly simplified schematic of S1P metabolic
pathway. Sphingosine (Sph) is catalyzed by Sphingosine kinase 1 or 2 (Sphks) to form S1P. S1P can be degraded reversibly by Sphingosine
phosphatase 1 or 2 (Sgpps) back to sphingosine or irreversibly by Sphingosine-1-phosphate lyase (Sgpl) into ethanolamine phosphate and
hexadecenal. Sphingosine can be converted to ceramide (Cer) by Ceramide synthase, the reverse reaction is catalyzed by Ceramidase. Cumulative
evidence from the literature suggests that S1P favors cell proliferation and promote survival while ceramide and sphingosine tend to drive cells into
apoptosis and cell cycle arrest. (B) In wild type embryo where there is equilibrium of sphingosine/ceramide and S1P, cell death and survival are kept
in balance. In the Sphk12/2;Sphk22/2 double mutant, not only is there an overall decrease in sphingolipids including sphingosine and ceramide,
S1P is completely absent. This results in a distortion of the sphingosine/ceramide to S1P ratio in the cells, which can tip the scale towards cell death
and decrease in cell proliferation.
doi:10.1371/journal.pone.0027150.g011
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